ArticleInvestigational new drugs2020

Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study.

Su Young Jung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.